Using lymph node fine needle aspirates for gene expression profiling of canine lymphoma

Area of Science:

• Veterinary Oncology
• Molecular Diagnostics
• Canine Cancer Research

Background:

• Current canine lymphoma classification lacks precision for tumors with similar appearances but different behaviors.
• Transcriptional profiling offers objective, clinically relevant stratification for canine lymphomas.
• Prognostic assays using transcriptional profiling could be performed on non-anesthetic needle aspirates.

Purpose of the Study:

• To compare gene expression profiles from surgical biopsies and fine needle aspirates (FNA) of canine lymphomas.
• To assess the feasibility of using FNA for transcriptional profiling in canine lymphoma diagnosis and prognosis.

Main Methods:

• Pilot study involving five canine lymphoma cases.
• Comparison of gene expression profiles between surgical biopsies and corresponding FNAs.
• Analysis of expression profile complexity and similarity using correlation coefficients.

Main Results:

• FNA-derived expression profiles showed high complexity and strong similarity (median correlation coefficient = 0.911) to surgical biopsy profiles.
• Observed gene expression differences suggest FNA samples may contain a purer lymphocyte population.
• High-quality expression profiles were consistently obtained from FNAs, even without a standardized collection protocol.

Conclusions:

• Fine needle aspirates are a robust and reliable source of tumor tissue for canine lymphoma transcriptional profiling.
• Transcriptional profiling of FNA samples holds promise for developing a non-invasive prognostic assay for canine lymphomas.
• This approach could lead to more objective and clinically relevant stratification of canine lymphoma cases.